# Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis

> **NCT00325338** · PHASE2 · COMPLETED · sponsor: **Allergy Therapeutics** · enrollment: 100 (—)

## Conditions studied

- Type I Hypersensitivity

## Interventions

- **BIOLOGICAL:** Ragweed MATAMPL

## Key facts

- **NCT ID:** NCT00325338
- **Lead sponsor:** Allergy Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 100 (—)
- **Last updated:** 2010-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00325338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00325338, "Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00325338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*